Latest AstraZeneca Stories
WILMINGTON, Del., March 31, 2015 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) reported that partner AstraZeneca announced today that MOVANTIK(TM) (naloxegol) has launched in the United States.
Since The Syngenta Lawsuit Multidistrict Litigation Was Established In December 2014, Nealy 500 Claims Have Been Filed In The Proceeding On Behalf Of Farmers Purportedly Incurred Financial Damages
Staying healthy can be difficult this time of year, make the struggle just a little easier with acid-free coffee.
SHANGHAI, March 27, 2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc.
BISHOPS STORTFORD, England, March 26, 2015 /PRNewswire/ -- Customer Speakers Include AstraZeneca Neuroscience iMed, Genentech, Celgene and Many Others Dotmatics
DALLAS, March 24, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Pandemic Influenza - Pipeline Review, H1 2015" therapeutic market research report of 135 pages with latest
RnRMarketResearch.com adds “Arterial Thrombosis – Pipeline Review, H1 2015” report to its store.
DALLAS, March 20, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Glomerulonephritis - Pipeline Review, H1 2015" report to its store.
- Scholarship essay topic focuses on The Good Growth Plan GREENSBORO, N.C., March 19, 2015 /PRNewswire/ -- Syngenta invites eligible university students to contribute to the ongoing ag sustainability
SAN FRANCISCO, March 19, 2015 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) reported that partner AstraZeneca today announced a co-commercialisation agreement with Daiichi Sankyo, Inc.
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.